Table 2 Median progression-free survival and overall survival by initial chemotherapy regimen
First line chemotherapy | N | Median PFS (95% CI) | Median OS (95% CI) |
|---|---|---|---|
No chemotherapy | 3 | 1.3 (0.5–2.1) | 1.3 (0.5–2.1) |
Ifosfamide/Paclitaxel | 7 | 8.0 (2.4–13.7) | 19.0 (16.4–21.6) |
Carboplatin/Paclitaxel | 15 | 17.8 (4.0–31.6) | 23.2 (22.0–24.4) |
Ifosfamide/Cisplatin | 4 | 13.0 (0.0–28.3) | 20.6 (0.0–65.2) |
Carboplatin/Cytoxan | 1 | 13.4 (NA) | 13.4 (NA) |
Adriamycin/Cisplatin | 1 | 213.2 (NA) | 213.2 (NA) |
Total | 31 | 9.3 (3.7–14.9) | 19.7 (15.7–23.6) |